Caspase-9 as a Potential Target for Pulmonary Fibrosis Treatment
A preclinical study suggests that blocking caspase-9, an enzyme involved in cell death, may be a potential treatment target for pulmonary fibrosis.
Researchers found that caspase-9 levels were elevated in lung tissue from people with pulmonary fibrosis (PF) and in a mouse model of the disease, particularly in diseased areas.
- Blocking caspase-9 activity reduced signs of cell death and lung fibrosis in the PF mouse model.
- Caspase-9 promoted lung fibrosis by triggering apoptosis and activating beta-catenin signaling.
Blocking caspase-9 may halt or reverse tissue scarring in pulmonary fibrosis.
Author's summary: Caspase-9 is a new target for treating pulmonary fibrosis.
More News
- Chipotle’s Stock Plunges 18% On Lowered Guidance
- Will ARC Raiders Survive? A Deep Dive Into Its Future | Invision Game Community
- Emmy-Winner Chronicles Yankees Icon Joe Torre’s MLB Legacy On Screen
- Over 2,700 People Denied Maltese Citizenship In Past Five Years
- Trump Goes Full Dictator With Bonkers Threat to Use Air Force and Navy in U.S. Cities
- The Tech Symphony: AI's Crescendo and the Gadget Orchestra
- VisitMalta Wins Gold At US Travel Awards For Second Year In A Row